{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:06:07Z","timestamp":1789473967177,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.endien.2026.501777","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:50:38Z","timestamp":1781553038000},"page":"501777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastrointestinal toxicity in the treatment of hematological tumors. Influence on nutritional status"],"prefix":"10.1016","volume":"73","author":[{"given":"Teresa","family":"Alonso Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Civera Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Garc\u00eda Malpartida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Gonz\u00e1lez Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Serna Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Williana M.","family":"Torres Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bol\u00edvar Luis","family":"D\u00edaz Jord\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Botella Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2026.501777_bib0005","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1101\/gad.284109.116","article-title":"Epigenetics of hematopoiesis and hematological malignancies","volume":"30","author":"Hu","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.endien.2026.501777_bib0010","unstructured":"Las cifras del c\u00e1ncer sangu\u00edneo en Espa\u00f1a. Proyecciones de incidencia para 2025 y estimaciones de supervivencia. Red Espa\u00f1ola de Registros de C\u00e1ncer (REDECAN) y Sociedad Espa\u00f1ola de Hematolog\u00eda y Hemoterapia (SEHH). NdP REDECAN-SEHH Cifras c\u00e1ncer hematol\u00f3gico.pdf."},{"key":"10.1016\/j.endien.2026.501777_bib0015","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical nutrition in cancer","volume":"36","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr."},{"key":"10.1016\/j.endien.2026.501777_bib0020","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/HS9.0000000000000332","article-title":"Malnutrition in older patients with hematological malignancies at initial diagnosis - association with impairments in health status, systemic inflammation and adverse outcome","volume":"4","author":"Stauder","year":"2020","journal-title":"Hemasphere."},{"key":"10.1016\/j.endien.2026.501777_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17474086.2022.2035717","article-title":"Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment","volume":"15","author":"Szeja","year":"2022","journal-title":"Expert Rev Hematol."},{"key":"10.1016\/j.endien.2026.501777_bib0030","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.3390\/cancers15184600","article-title":"Sarcopenia diagnosis and management in hematological malignancies and differences with cachexia and frailty","volume":"15","author":"Colloca","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.endien.2026.501777_bib0035","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.4081\/ejtm.2018.7587","article-title":"Chemotherapy-induced muscle wasting: an update","volume":"28","author":"Coletti","year":"2018","journal-title":"Eur J Transl Myol."},{"key":"10.1016\/j.endien.2026.501777_bib0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s11739-020-02589-5","article-title":"Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis","volume":"16","author":"Rinninella","year":"2021","journal-title":"Intern Emerg Med."},{"key":"10.1016\/j.endien.2026.501777_bib0045","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1016\/j.clnu.2021.08.023","article-title":"Low skeletal muscle is a predictor of treatment related toxicity in oncologic patients. A meta-analysis","volume":"40","author":"Surov","year":"2021","journal-title":"Clin Nutr."},{"key":"10.1016\/j.endien.2026.501777_bib0050","first-page":"1441","article-title":"The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy","volume":"28","author":"Yilmaz","year":"2020","journal-title":"Supp Care Cancer."},{"key":"10.1016\/j.endien.2026.501777_bib0055","first-page":"136","article-title":"Digestive toxicity in cancer treatments. Bibliographic review. Influence on nutritional status","volume":"70","author":"Alonso Dom\u00ednguez","year":"2023","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)."},{"key":"10.1016\/j.endien.2026.501777_bib0060","series-title":"Pautas de Quimioterapia y Nuevos Agentes en Hemopat\u00edas Malignas. Programa Espa\u00f1ol de Tratamientos en Hematolog\u00eda. FEHH (Fundaci\u00f3n Espa\u00f1ola de Hematolog\u00eda y Hemoterapia)","author":"Salinas","year":"2024"},{"key":"10.1016\/j.endien.2026.501777_bib0065","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/leu.2016.104","article-title":"European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia","volume":"30","author":"Steegmann","year":"2016","journal-title":"Leukemia."},{"key":"10.1016\/j.endien.2026.501777_bib0070","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3390\/cancers13071643","article-title":"Analysis of gastrointestinal adverse events from tyrosine kinase inhibitors for chronic myeloid leukemia","volume":"13","author":"Mohanavelu","year":"2021","journal-title":"Cancers."},{"key":"10.1016\/j.endien.2026.501777_bib0075","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1200\/JCO.18.01994","article-title":"Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-Cell lymphoma: clinical outcomes of the phase III intergroup trial alliance\/CALGB 50303","volume":"37","author":"Bartlett","year":"2019","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endien.2026.501777_bib0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa2115304","article-title":"Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma","volume":"386","author":"Tilly","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endien.2026.501777_bib0085","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","article-title":"Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma","volume":"387","author":"Chari","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endien.2026.501777_bib0090","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1038\/s41375-020-0756-6","article-title":"Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials","volume":"34","author":"Gavriatopoulou","year":"2020","journal-title":"Leukemia."},{"key":"10.1016\/j.endien.2026.501777_bib0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-019-0198-4","article-title":"Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma","volume":"9","author":"Martin","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.endien.2026.501777_bib0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa2203478","article-title":"Teclistamab in relapsed or refractory multiple myeloma","volume":"387","author":"Moreau","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endien.2026.501777_bib0105","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/s41591-023-02528-9","article-title":"Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results","volume":"29","author":"Lesokhin","year":"2023","journal-title":"Nat Med."},{"key":"10.1016\/j.endien.2026.501777_bib0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2147\/JBM.S317966","article-title":"Profile and management of toxicity of selinexor and belantamab mafodotin for the treatment of triple class refractory multiple myeloma","volume":"12","author":"Neupane","year":"2021","journal-title":"J Blood Med."},{"key":"10.1016\/j.endien.2026.501777_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/gastro\/goz065","article-title":"Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy","volume":"8","author":"Rajha","year":"2020","journal-title":"Gastroenterol Rep."},{"key":"10.1016\/j.endien.2026.501777_bib0120","first-page":"680","article-title":"Inmune checkpoint inhibitor-induced diarrea and colitis: an overview","volume":"32","author":"Zoghbi","year":"2024","journal-title":"Support Care Cancer."},{"key":"10.1016\/j.endien.2026.501777_bib0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/cis998","article-title":"Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy","volume":"56","author":"Nesher","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.endien.2026.501777_bib0130","first-page":"102","article-title":"participants of the MASCC\/ESMO Consensus Conference 2022. Electronic address: clinicalguidelines@esmo.org, et al. 2023 MASCC and ESMO guideline update for thr prevention of chemotherapy-and radiotherapy-induced nausea and vomiting","volume":"9","author":"Herrstedt","year":"2024","journal-title":"ESMO Open."},{"key":"10.1016\/j.endien.2026.501777_bib0135","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer."},{"issue":"Supplement 4","key":"10.1016\/j.endien.2026.501777_bib0140","doi-asserted-by":"crossref","first-page":"iv126","DOI":"10.1093\/annonc\/mdy145","article-title":"Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Bossi","year":"2018","journal-title":"Ann Oncol."},{"key":"10.1016\/j.endien.2026.501777_bib0145","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ncp.11152","article-title":"Considerations for medical nutrition therapy management of the critically ill patient with hematological malignancies: a narrative review","volume":"39","author":"Lopez-Delgado","year":"2024","journal-title":"Nutr Clin Pract."},{"key":"10.1016\/j.endien.2026.501777_bib0150","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa022473","article-title":"German Hodgkin's Lymphoma Study Group. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin\u2019s disease","volume":"348","author":"Diehl","year":"2003","journal-title":"N Engl J Med."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026001204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026001204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:39:54Z","timestamp":1789472394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018026001204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2530018026001204"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2026.501777","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal toxicity in the treatment of hematological tumors. Influence on nutritional status","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2026.501777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2026.501777","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEEN and SED.","name":"copyright","label":"Copyright"}],"article-number":"501777"}}